Evidence-Based Medicine Guidelines
Betahistine for Ménière's disease and vertigo
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Betahistine for Ménière's Disease and Vertigo." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452838/0/__________Betahistine_for_M.
Betahistine for Ménière's disease and vertigo. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/0/__________Betahistine_for_M. Accessed April 23, 2025.
Betahistine for Ménière's disease and vertigo. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/0/__________Betahistine_for_M
Betahistine for Ménière's Disease and Vertigo [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/0/__________Betahistine_for_M.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Betahistine for Ménière's disease and vertigo
ID - 452838
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/0/__________Betahistine_for_M
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
